| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.267 | 45.821 | 39.647 | 49.972 | 44.267 | 47.938 | 44.196 | 42.707 | 39.813 | 7.881 |
| Total Income - EUR | 36.267 | 45.821 | 39.647 | 49.972 | 44.267 | 47.938 | 44.196 | 44.670 | 39.813 | 7.881 |
| Total Expenses - EUR | 28.755 | 36.574 | 30.257 | 37.029 | 31.413 | 32.387 | 29.976 | 33.491 | 25.933 | 5.889 |
| Gross Profit/Loss - EUR | 7.512 | 9.247 | 9.391 | 12.943 | 12.854 | 15.552 | 14.219 | 11.179 | 13.880 | 1.992 |
| Net Profit/Loss - EUR | 6.424 | 7.866 | 8.200 | 11.444 | 11.524 | 14.571 | 12.920 | 9.924 | 11.993 | 1.675 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Crisdeea Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.852 | 8.530 | 8.679 | 12.065 | 12.102 | 14.841 | 13.412 | 10.834 | 14.462 | 1.723 |
| Inventories | 3.083 | 1.672 | 4.420 | 1.769 | 3.137 | 2.252 | 2.806 | 4.381 | 4.352 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 9.825 | 0 | 0 | 1.723 |
| Cash | 3.768 | 6.858 | 4.259 | 10.297 | 8.965 | 12.588 | 781 | 6.453 | 10.110 | 0 |
| Shareholders Funds | 6.469 | 7.920 | 8.253 | 11.495 | 11.574 | 14.620 | 12.969 | 9.972 | 14.253 | 1.723 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 406 | 610 | 426 | 570 | 527 | 220 | 443 | 862 | 209 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Crisdeea Bio Srl